This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hubei Zhangjun Biotech Co.,ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Na Li - Innovator in Flavivirus Research
Na Li is a prominent inventor based in Wuhan, China. She is currently associated with Raycan Technology Co., Ltd., where she focuses on groundbreaking research in the field of virology. Her work primarily revolves around the development of innovative solutions for vaccine strains.
Latest Patent Applications:
Na Li has submitted a significant patent application titled "Attenuated Virus of Flavivirus Virus and Use Thereof." This application presents an attenuated virus of a flavivirus, which includes a polyadenylic acid (poly(A)) sequence. The poly(A) sequence replaces a portion of the nucleotide sequence in the 3′ untranslated region (3′UTR) of the flavivirus. The design ensures that the 3′ untranslated region retains a 3′-end stem loop region (3′SL). This innovative approach aims to prepare safe and effective attenuated vaccine strains.
Conclusion:
Na Li's contributions to flavivirus research highlight her commitment to advancing vaccine technology. Her innovative patent application reflects her dedication to improving public health through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile